Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 8;17:4059–4071. doi: 10.2147/IJN.S380598

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Zou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Inhibitory effects of S-HDL on ovarian cancer xenografted mice. (A) Overall tumor formation in nude mice. (B) Tumor in xenografted mice after being treated with Saline, S-HDL (l) (200μg/kg S-HDL), S-HDL (h) (400μg/kg S-HDL), S-HDL+DDP (200μg/kg S-HDL combined with 1mg/kg cisplatin), DDP (2mg/kg cisplatin), and Sal (400μg/kg Sal) for 3 weeks. (C) Tumor weight of different groups. (D) The ratio of tumor weight to body mass (, n=6) (*P < 0.05, **P < 0.01, ***P < 0.001, *compared with Saline treatment group; ^##P < 0.01, ^#compared with Sal treatment group).

Inline graphic — Inhibitory effects of S-HDL on ovarian cancer xenografted mice. (A) Overall tumor formation in nude mice. (B) Tumor in xenografted mice after being treated with Saline, S-HDL (l) (200μg/kg S-HDL), S-HDL (h) (400μg/kg S-HDL), S-HDL+DDP (200μg/kg S-HDL combined with 1mg/kg cisplatin), DDP (2mg/kg cisplatin), and Sal (400μg/kg Sal) for 3 weeks. (C) Tumor weight of different groups. (D) The ratio of tumor weight to body mass (, n=6) (*P < 0.05, **P < 0.01, ***P < 0.001, *compared with Saline treatment group; ^##P < 0.01, ^#compared with Sal treatment group).